National Comprehensive Cancer Network

NCCN Oncology Research Program (ORP)
NCCN Enzalutamide Research Grant Opportunity Submit by April 27, 2015
Study Proposal Submission-NCCN RMS
ORP Recent News
ORP Affiliate Research Consortium
ORP Scientific Publications
ORP for Industry
ORP Investigator Steering Committee
ORP Testimonials
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
ORP Grant History
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
Specialized Imaging Research Consortium™ (SIRC)
ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources

NCCN Drugs & Biologics Compendium™ Chapters for Neuroendocrine Tumors

Updated versions of the NCCN Drugs & Biologics Compendium™ chapters for Neuroendocrine Tumors have been published by the National Comprehensive Cancer Network. Among the updates, a new chapter has been added for adrenal gland tumors. The current version is now version 2.2009.